Trials / Completed
CompletedNCT01363024
Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
An Open-Label, Multicenter, Phase I Dose-Escalation Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, open-label, dose-escalation study to assess the safety, tolerability and Pharmacokinetics of MGFR1877S.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MFGR1877S | Intravenous escalating dose |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2011-06-01
- Last updated
- 2016-11-02
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01363024. Inclusion in this directory is not an endorsement.